Lubner David Charles
CIK: 0001572000
Director
Primary company: TETRAPHASE PHARMACEUTICALS INC (TTPH)
Lubner David Charles is a corporate insider at TETRAPHASE PHARMACEUTICALS INC (TTPH) filing SEC Form 4 transactions. 101 transactions across 10 companies, totaling $524,658 in purchases and $2,523,986 in sales. Source: SEC EDGAR.
Companies
Transaction History
Source: SEC EDGAR Form 4 insider transaction filings.
Company | Type | Shares | Price | Value | Shares After | Date | SEC |
|---|---|---|---|---|---|---|---|
| Award | 35,152 | $17.04 | $599K | 35,152 | 6/5/2026 Filed: 6/5/2026 | Filing → | |
CRESCENT BIOPHARMA, INC. CBIO | Award | 11,050 | $17.01 | $188K | 11,050 | 6/2/2026 Filed: 6/2/2026 | Filing → |
| Disposition | 25,000 | - | - | 0 | 8/19/2025 Filed: 8/19/2025 | Filing → | |
GLYCOMIMETICS INC CBIO | Award | 9,023 | - | - | 9,023 | 6/23/2025 Filed: 6/23/2025 | Filing → |
| Award | 25,000 | - | - | 25,000 | 6/18/2025 Filed: 6/20/2025 | Filing → | |
| Award | 35,000 | - | - | 35,000 | 5/30/2025 Filed: 6/3/2025 | Filing → | |
Arcellx, Inc. ACLX | Award | 9,174 | - | - | 9,174 | 5/29/2025 Filed: 5/30/2025 | Filing → |
| Award | 30,000 | - | - | 30,000 | 5/22/2025 Filed: 5/23/2025 | Filing → | |
| Award | 23,742 | - | - | 23,742 | 6/4/2024 Filed: 6/6/2024 | Filing → | |
Arcellx, Inc. ACLX | Award | 8,011 | - | - | 8,011 | 5/28/2024 Filed: 6/6/2024 | Filing → |
| Award | 30,000 | - | - | 30,000 | 5/23/2024 Filed: 5/28/2024 | Filing → | |
| Award | 25,133 | - | - | 25,133 | 5/22/2024 Filed: 5/24/2024 | Filing → | |
POINT Biopharma Global Inc. PNT | Disposition | 44,749 | - | - | 0 | 12/27/2023 Filed: 12/27/2023 | Filing → |
POINT Biopharma Global Inc. PNT | Disposition | 25,614 | - | - | 0 | 12/27/2023 Filed: 12/27/2023 | Filing → |
POINT Biopharma Global Inc. PNT | Disposition | 25,000 | - | - | 0 | 12/27/2023 Filed: 12/27/2023 | Filing → |
POINT Biopharma Global Inc. PNT | Disposition | 3,600 | - | - | 0 | 12/27/2023 Filed: 12/27/2023 | Filing → |
POINT Biopharma Global Inc. PNT | U | 35,400 | - | - | 3,600 | 12/26/2023 Filed: 12/27/2023 | Filing → |
| Award | 25,000 | $0.00 | $0 | 25,000 | 11/9/2023 Filed: 11/13/2023 | Filing → | |
Arcellx, Inc. ACLX | Award | 11,459 | $0.00 | $0 | 11,459 | 6/14/2023 Filed: 6/16/2023 | Filing → |
POINT Biopharma Global Inc. PNT | Award | 44,749 | $0.00 | $0 | 44,749 | 6/1/2023 Filed: 6/5/2023 | Filing → |
Type
Award
Shares
35,152
Price
$17.04
Value
$599K
CRESCENT BIOPHARMA, INC.
CBIO
Type
Award
Shares
11,050
Price
$17.01
Value
$188K
Type
Disposition
Shares
25,000
Price
-
Value
-
GLYCOMIMETICS INC
CBIO
Type
Award
Shares
9,023
Price
-
Value
-
Type
Award
Shares
25,000
Price
-
Value
-
Type
Award
Shares
35,000
Price
-
Value
-
Arcellx, Inc.
ACLX
Type
Award
Shares
9,174
Price
-
Value
-
Type
Award
Shares
30,000
Price
-
Value
-
Type
Award
Shares
23,742
Price
-
Value
-
Arcellx, Inc.
ACLX
Type
Award
Shares
8,011
Price
-
Value
-
Type
Award
Shares
30,000
Price
-
Value
-
Type
Award
Shares
25,133
Price
-
Value
-
POINT Biopharma Global Inc.
PNT
Type
Disposition
Shares
44,749
Price
-
Value
-
POINT Biopharma Global Inc.
PNT
Type
Disposition
Shares
25,614
Price
-
Value
-
POINT Biopharma Global Inc.
PNT
Type
Disposition
Shares
25,000
Price
-
Value
-
POINT Biopharma Global Inc.
PNT
Type
Disposition
Shares
3,600
Price
-
Value
-
POINT Biopharma Global Inc.
PNT
Type
U
Shares
35,400
Price
-
Value
-
Type
Award
Shares
25,000
Price
$0.00
Value
$0
Arcellx, Inc.
ACLX
Type
Award
Shares
11,459
Price
$0.00
Value
$0
POINT Biopharma Global Inc.
PNT
Type
Award
Shares
44,749
Price
$0.00
Value
$0
AI Agent
Try asking...